Edition:
United Kingdom

People: Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

107.83USD
17 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$107.83
Open
$108.86
Day's High
$109.22
Day's Low
$107.74
Volume
548,127
Avg. Vol
708,298
52-wk High
$141.81
52-wk Low
$92.57

Chiniara, Ellen 

Ms. Ellen Chiniara is Executive Vice President, General Counsel, Corporate Secretary of Company.she is responsible for overseeing all global legal matters for the Company. Prior to joining Alexion in January 2018, Ms. Chiniara was Senior Vice President and General Counsel of Alere Inc., a point-of-care diagnostics company, from October 2006 to October 2017 where she was responsible for all legal matters and, from June 2014 to October 2017 she had oversight of compliance and government affairs matters. She managed the legal aspects of the company’s numerous acquisitions and dispositions and was also the executive sponsor of Alere’s corporate social responsibility efforts. Prior to joining Alere, Ms. Chiniara served as Associate General Counsel for Serono’s Neurology division from 2002 to 2006. Earlier in her career, Ms. Chiniara was a partner at the law firm Hale and Dorr LLP (now Wilmer Cutler Pickering Hale and Dorr LLP). Ms. Chiniara received her J.D. from Stanford University’s School of Law and her Bachelor's Degree from Bryn Mawr College. She also was a graduate fellow at Yale University in Slavic Languages.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Brennan

448,858

Ludwig Hantson

16,490,200

Paul Clancy

5,486,510

Indrani Franchini

--

Ellen Chiniara

--

Anne-Marie Law

5,296,490
As Of  31 Dec 2018